Goldman Sachs Group Inc. Purchases 686,751 Shares of The Cooper Companies, Inc. $COO

Key Points

• Goldman Sachs Group Inc. raised its stake in The Cooper Companies by 17.0%, now owning approximately 4.73 million shares worth about $399.34 million.
• Cooper Companies reported a quarterly earnings per share (EPS) of $1.10, exceeding analysts' estimates of $1.07, alongside a revenue of $1.06 billion.
• A variety of institutional investors are increasing their holdings in Cooper Companies, with insider transactions also indicating growing confidence, as reported by executive purchases at prices around $65 per share.

Goldman Sachs Group Inc. grew its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 17.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 4,734,327 shares of the medical device company's stock after purchasing an additional 686,751 shares during the period. Goldman Sachs Group Inc. owned 2.37% of Cooper Companies worth $399,340,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of COO. Captrust Financial Advisors grew its position in shares of Cooper Companies by 19.0% during the fourth quarter. Captrust Financial Advisors now owns 4,542 shares of the medical device company's stock worth $418,000 after acquiring an additional 726 shares during the last quarter. Cetera Investment Advisers grew its position in Cooper Companies by 1.3% in the 4th quarter. Cetera Investment Advisers now owns 24,049 shares of the medical device company's stock valued at $2,211,000 after buying an additional 312 shares in the last quarter. Crestline Management LP bought a new position in shares of Cooper Companies during the 4th quarter valued at about $286,000. EP Wealth Advisors LLC boosted its position in shares of Cooper Companies by 4.6% during the 4th quarter. EP Wealth Advisors LLC now owns 4,438 shares of the medical device company's stock valued at $408,000 after purchasing an additional 194 shares in the last quarter. Finally, DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main raised its position in shares of Cooper Companies by 3,201.3% during the fourth quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main now owns 15,846 shares of the medical device company's stock worth $1,457,000 after purchasing an additional 15,366 shares during the period. Institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

COO has been the subject of several recent analyst reports. Loop Capital set a $100.00 target price on shares of Cooper Companies in a report on Tuesday, June 17th. BNP Paribas upgraded shares of Cooper Companies from a "hold" rating to a "strong-buy" rating in a report on Tuesday, July 22nd. Wall Street Zen cut shares of Cooper Companies from a "buy" rating to a "hold" rating in a report on Saturday, July 12th. Mizuho reduced their price target on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating for the company in a research report on Wednesday, July 16th. Finally, Needham & Company LLC reissued a "buy" rating and issued a $94.00 price target on shares of Cooper Companies in a research report on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and two have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Cooper Companies has an average rating of "Moderate Buy" and a consensus target price of $86.64.

Cooper Companies Stock Down 2.6%

Shares of NASDAQ COO traded down $1.78 during mid-day trading on Friday, reaching $66.68. The company had a trading volume of 3,147,814 shares, compared to its average volume of 3,323,522. The stock has a fifty day moving average of $71.53 and a two-hundred day moving average of $75.80. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.24 and a current ratio of 2.12. The company has a market capitalization of $13.26 billion, a price-to-earnings ratio of 32.85, a PEG ratio of 1.75 and a beta of 0.97. The Cooper Companies, Inc. has a 12-month low of $61.78 and a 12-month high of $112.38.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings data on Wednesday, August 27th. The medical device company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.07 by $0.03. The firm had revenue of $1.06 billion for the quarter, compared to analyst estimates of $1.06 billion. Cooper Companies had a net margin of 10.08% and a return on equity of 9.82%. The company's revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.96 earnings per share. Cooper Companies has set its Q4 2025 guidance at 1.100-1.140 EPS. FY 2025 guidance at 4.080-4.120 EPS. As a group, equities research analysts expect that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other Cooper Companies news, COO Daniel G. Mcbride acquired 3,000 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The shares were purchased at an average price of $65.04 per share, with a total value of $195,120.00. Following the completion of the transaction, the chief operating officer owned 63,120 shares in the company, valued at $4,105,324.80. The trade was a 4.99% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Brian G. Andrews acquired 1,525 shares of the business's stock in a transaction that occurred on Tuesday, September 2nd. The shares were acquired at an average cost of $65.68 per share, for a total transaction of $100,162.00. Following the transaction, the executive vice president owned 22,191 shares of the company's stock, valued at approximately $1,457,504.88. This represents a 7.38% increase in their position. The disclosure for this purchase can be found here. Insiders bought a total of 15,975 shares of company stock worth $1,079,566 in the last ninety days. Insiders own 1.98% of the company's stock.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.